Literature DB >> 2784767

MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors.

A Risso1, M E Cosulich, A Rubartelli, M R Mazza, A Bargellesi.   

Abstract

MLR3 molecule is a membrane glycoprotein (mol. mass range 28-34 kDa) present on activated, but not resting human peripheral T cells, B cells and thymocytes. Its kinetics of appearance on the cell surface (3 h after the addition of the inductive signal to the cells) suggests that it is an early activation antigen. The proliferative response of cultured T and B lymphocytes and thymocytes to different activation signals is inhibited by the addition of MLR3 monoclonal antibody. Moreover the antibody in combination with non-mitogenic doses of phorbol myristate acetate leads to proliferation of thymocytes and resting B and T lymphocytes. In the latter, synthesis of interleukin 2 is also induced. Biochemical analysis of MLR3 antigen indicates that it is a phosphorylated protein with N-linked sugar moieties. Together these data suggest a role for MLR3 antigen in the signal transduction process during activation, both for mature lymphocytes and for T cell precursors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784767     DOI: 10.1002/eji.1830190216

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

Authors:  C Cambiaggi; M T Scupoli; T Cestari; F Gerosa; G Carra; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Expression of CD69 activation marker by endometrial granulated lymphocytes throughout the menstrual cycle and in early pregnancy.

Authors:  N Vassiliadou; J N Bulmer
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

3.  Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene.

Authors:  B Plougastel; T Jones; J Trowsdale
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia.

Authors:  T Tak; B Hilvering; K Tesselaar; L Koenderman
Journal:  Clin Exp Immunol       Date:  2015-09-16       Impact factor: 4.330

5.  Expression of early activation antigen (CD69) during human thymic development.

Authors:  L K Jung; B F Haynes; S Nakamura; S Pahwa; S M Fu
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

6.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

7.  CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.

Authors:  A Hartnell; D S Robinson; A B Kay; A J Wardlaw
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

8.  Activation of lymphocytes after platelet allotransfusion possessing only class I MHC product.

Authors:  E Pócsik; R Mihalik; E Gyódi; M Réti; K Pálóczi; G G Petrányi; M Benczúr
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

9.  Allopurinol reduces antigen-specific and polyclonal activation of human T cells.

Authors:  Damián Pérez-Mazliah; María C Albareda; María G Alvarez; Bruno Lococo; Graciela L Bertocchi; Marcos Petti; Rodolfo J Viotti; Susana A Laucella
Journal:  Front Immunol       Date:  2012-09-21       Impact factor: 7.561

10.  CD69 does not affect the extent of T cell priming.

Authors:  Elisenda Alari-Pahissa; Laura Notario; Elena Lorente; Javier Vega-Ramos; Ana Justel; Daniel López; José A Villadangos; Pilar Lauzurica
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.